Interne link ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference juni 04, 2018 om 11:00 AM UTC
Interne link ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board mei 23, 2018 om 11:00 AM UTC
Interne link ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB april 30, 2018 om 11:00 AM UTC
Interne link ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO april 23, 2018 om 11:00 AM UTC
Interne link ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology april 10, 2018 om 11:00 AM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update februari 28, 2018 om 12:00 PM UTC
Interne link ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer februari 27, 2018 om 12:00 PM UTC
Interne link Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A februari 12, 2018 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific Meeting and Investor Conference februari 06, 2018 om 12:00 PM UTC
Interne link ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology januari 08, 2018 om 12:00 PM UTC
Interne link ProQR Announces R&D Day and Provides Update on Innovation Portfolio november 30, 2015 om 12:00 PM UTC
Interne link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials november 23, 2015 om 11:30 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences oktober 01, 2015 om 11:00 AM UTC
Interne link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable september 23, 2015 om 11:00 AM UTC
Interne link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment september 14, 2015 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2015 augustus 19, 2015 om 11:59 AM UTC
Interne link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients juni 26, 2015 om 11:54 AM UTC
Interne link ProQR to Present at the JMP Securities Life Science Conference juni 16, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the First Quarter of 2015 mei 21, 2015 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in May april 29, 2015 om 11:00 AM UTC